Xiaoping Duan
Impact in
- General Energy top 10%
-
- Bone health and treatments
- CAR-T cell therapy research
Papers in
-
- RNA Interference and Gene Delivery 4
- Angiogenesis and VEGF in Cancer 2
-
- Sarcoma Diagnosis and Treatment 6
- Co-authors
- Eugenie S. Kleinerman (11 shared papers)Zhichao Zhou (6 shared papers)Hui Guan (5 shared papers)Shu-Fang Jia (4 shared papers)Zhoutao Chen (1 shared paper)Nadezhda V. Koshkina (2 shared papers)Laura L. Worth (2 shared papers)Ying Cao (2 shared papers)
- Journals
- Cancer (3 papers)Clinical Cancer Research (3 papers)Resources Policy (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)Environmental Pollution (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Xiaoping Duan
14 papers receiving 597 citations
Peers
Comparison fields: 5 of 94
- General Energy 12
- Oncology 192
- Cancer Research 83
- Immunology and Allergy 33
- Pulmonary and Respiratory Medicine 173
Countries citing papers authored by Xiaoping Duan
This map shows the geographic impact of Xiaoping Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Duan more than expected).
Fields of papers citing papers by Xiaoping Duan
This network shows the impact of papers produced by Xiaoping Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Duan. The network helps show where Xiaoping Duan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 91 | |
| 2 | 2004 | 74 | |
| 3 | 2023 | 64 | |
| 4 | 2008 | 61 | |
| 5 | 2005 | 57 | |
| 6 | Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. | 2003 | 53 |
| 7 | 2011 | 44 | |
| 8 | 2007 | 42 | |
| 9 | 2005 | 36 | |
| 10 | 2006 | 32 | |
| 11 | 2009 | 21 | |
| 12 | 2004 | 13 | |
| 13 | 2023 | 11 | |
| 14 | VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. | 2008 | 8 |
About Xiaoping Duan
Xiaoping Duan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Immunology, having authored 14 papers that have together received 607 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), RNA Interference and Gene Delivery (4 papers), Virus-based gene therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Bone health and treatments (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in General Energy (12 citations), Oncology (192 citations), Cancer Research (83 citations), Immunology and Allergy (33 citations) and Pulmonary and Respiratory Medicine (173 citations). Xiaoping Duan has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Eugenie S. Kleinerman, Zhichao Zhou, Hui Guan, Shu-Fang Jia, Zhoutao Chen, Nadezhda V. Koshkina, Laura L. Worth, Ying Cao, Ying Cao and Hui Guan. Their work appears in journals such as Cancer, Clinical Cancer Research, Resources Policy, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and Environmental Pollution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.